Ecraprost (LTT Bio-Pharma)

N/A

Report date: 2025/03/10 16:59:19

Base Information

Drug NameEcraprost (LTT Bio-Pharma)
Drug Alias NameLT 2001AS 013
ClassificationSmall molecules
Mechanisms of ActionProstanoid EP1 receptor agonists
TargetsProstanoid EP1 receptor
Therapy Area/IndicationsPeripheral arterial occlusive disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesLTT Bio-Pharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLTT Bio-Pharma Co Ltd
Inactive CompaniesN/A
Active IndicationsPeripheral arterial occlusive disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A